Home › Funds › Rock Springs Capital Management LP › MLYS

Rock Springs Capital Management LP position in MLYS

MINERALYS THERAPEUTICS INC · Health Care

Rock Springs Capital Management LP reported holding 484,951 shares of MLYS (MINERALYS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$12.2M, representing 0.66% of its reported portfolio and ranking #49 among its reported holdings. Rock Springs Capital Management LP has disclosed MLYS holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)484.95K sh
Reported value held$12.19M
Portfolio Weight0.66%
First reportedQ3 2023
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Rock Springs Capital Management LP's MLYS position evolved

Rock Springs Capital Management LP first disclosed a stake in MLYS in Q3 2023 at 1,167,492 shares (US$11.1M). The position peaked in Q4 2025 at 427,596 shares, worth US$15.5M. Across 11 filings, Rock Springs Capital Management LP increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 484,951 shares valued at US$12.2M. Notable position changes include a 32% trim in Q1 2024 (shares fell 9% over the following quarter), a 52% trim in Q2 2024 (shares rose 4% over the following quarter), a 26% increase in Q3 2025 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.17M $11.10M New
Q4 2023 1.17M $10.04M Hold
Q1 2024 792.62K $10.23M Reduce
Q2 2024 378.93K $4.43M Reduce
Q1 2025 320.81K $5.09M New
Q2 2025 324.51K $4.39M Add
Q3 2025 408.31K $15.48M Add
Q4 2025 427.60K $15.52M Add
Q1 2026 439.75K $11.91M Add
Q2 2026 484.95K $13.08M Add
Q3 2026 484.95K $12.19M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MLYS and 13F data

MLYS (MINERALYS THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in MLYS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$207.6M), Catalys Pacific, LLC (US$196.0M), Samsara BioCapital, LLC (US$158.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MLYS

All MLYS fund holders →

FAQ

How long has Rock Springs Capital Management LP held MLYS?

Rock Springs Capital Management LP has disclosed MLYS holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

What is Rock Springs Capital Management LP's current position in MLYS?

As of Q3 2026, Rock Springs Capital Management LP holds 484.95K shares of MLYS (MINERALYS THERAPEUTICS INC), valued at $12.19M, representing 0.66% of its reported portfolio and ranking #49.

Has Rock Springs Capital Management LP been buying or selling MLYS?

In the latest 13F filing (Q3 2026), Rock Springs Capital Management LP held unchanged its position in MLYS. The position peaked in Q4 2025 at 427.60K shares.

Which other funds hold MLYS?

Other major institutional holders of MLYS include RA CAPITAL MANAGEMENT, L.P., Catalys Pacific, LLC, Samsara BioCapital, LLC, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.